Abstract B073: Radiotherapy dosing in intracranial ependymoma using the National Cancer Database
Bibliographic record
Abstract
Abstract Purpose: To determine the dose-dependent effect of adjuvant radiotherapy on survival for pediatric intracranial ependymomas and explore patient/disease characteristics that may benefit from higher doses using survival data. Methods: Data was accessed from the National Cancer Database and included patient data from 2004-2021. Inclusion criteria was comprised of a diagnosis of non-metastatic intracranial ependymoma, World Health Organization (WHO) grade I or II, surgical resection, adjuvant radiotherapy between 4500-6300cGy, and had survivorship data. Patients were included up to the age of 22 years. Crude and adjusted Cox proportional hazard ratios (HRs) were calculated to estimate the associations of patient, tumor, and treatment characteristics with overall survival (OS). Kaplan-Meier (KM) curves were used to visualize survival data for dosing for the general cohort and by subgroups (age, resection extent, and grade). Statistical significance was defined as p<0.05. Results: Our study included 1154 patients who met inclusion criteria, of whom 405 (35%) received ≤5400cGy and 749 (65%) received >5400cGy. Those who received <5400cGy tended to be younger, and were more likely to have tumors that were WHO grade II and/or located in the infratentorial area. We found no difference in crude (0.95, 95% CI 0.72-1.06, p=0.69) or adjusted (0.88, 0.46-1.69, p=0.71) OS HR for those receiving ≤5400cGy compared to >5400cGy. Likewise, there was no statistical difference in crude or adjusted OS HR for age ≤3years (1.09, 95% CI 0.84-1.41, and 1.17, 95% CI 0.62-2.18, respectively) or surgical resection extent (1.07, 95% CI 0.68-1.67, and 0.94, 95% CI 0.47-1.86, respectively). Crude OS HR for WHO grade III was 1.95 (95% CI 1.43-2.65, p<0.001) and adjusted was 3.12 (95% CI 1.49-6.52, p=0.002), compared to WHO grade II. On KM curves there was no difference in OS for radiotherapy for the general cohort based on dose alone, dose by age ≤3years, dose by surgical extent, or dose by grade. However, we did find better OS in those with grade II tumors compared to III regardless of radiotherapy dose received. Conclusions: There was no difference in OS between patients who received ≤5400cGy compared to >5400cGy. We found improved OS in those with grade II tumors compared to grade III, however there was no difference in survival based on dose received by tumor grade, age, or resection extent. Limitations in data available prevented exploring local control, event free survival, or toxicity. Future research should focus on identifying tumor or patient characteristics that would benefit from higher radiotherapy doses. Citation Format: Melanie L. Rose, Erika L. Moen, Bryan Ager, Benjamin V.M. Bajaj, Matthew Poppe, Gregory A. Russo, Torunn I. Yock. Radiotherapy dosing in intracranial ependymoma using the National Cancer Database [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research; 2024 Sep 5-8; Toronto, Ontario, Canada. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl):Abstract nr B073.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.002 | 0.011 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.002 | 0.007 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.001 | 0.000 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.002 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".